|
5XN1
HIV-1 reverse transcriptase Q151M:DNA:entecavir-triphosphate ternary complex
Deposited 2017-05-17
|
Different construct
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Homooligomer;Protein × 2
PDB declaration: trimeric
|
Chain A
100–654(555 aa)
Fragment:p66 subunit (UNP RESIDUES 100-654)
Chain B
100–527(428 aa)
Fragment:p51 subunit (UNP RESIDUES 100-527)
|
Mutation:Q151M, C162S, C280S
Mutation:C162S, C280S
|
ET9 [[(1R,3S,5S)-3-(2-azanyl-6-oxidanylidene-3H-purin-9-yl)-2-methylidene-5-oxidanyl-cyclopentyl]methoxy-oxidanyl-phosphory l] phosphono hydrogen phosphate × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;20 mM bis-Tris-HCl pH 6.0, 60 mM di-ammonium hydrogen citrate, 20 mM MgCl2, 1.5-3% PEG 6000, 2-4% sucrose, 4-8% glycerol
|
Resolution 2.45 Å
R-free 0.227
|
|
5XN1
HIV-1 reverse transcriptase Q151M:DNA:entecavir-triphosphate ternary complex
Deposited 2017-05-17
|
Different construct
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein–DNA
Homooligomer;Protein × 2
PDB declaration: trimeric
|
Chain C
100–654(555 aa)
Fragment:p66 subunit (UNP RESIDUES 100-654)
Chain D
100–527(428 aa)
Fragment:p51 subunit (UNP RESIDUES 100-527)
|
Mutation:Q151M, C162S, C280S
Mutation:C162S, C280S
|
ET9 [[(1R,3S,5S)-3-(2-azanyl-6-oxidanylidene-3H-purin-9-yl)-2-methylidene-5-oxidanyl-cyclopentyl]methoxy-oxidanyl-phosphory l] phosphono hydrogen phosphate × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;20 mM bis-Tris-HCl pH 6.0, 60 mM di-ammonium hydrogen citrate, 20 mM MgCl2, 1.5-3% PEG 6000, 2-4% sucrose, 4-8% glycerol
|
Resolution 2.45 Å
R-free 0.227
|
|
5XN2
HIV-1 reverse transcriptase Q151M:DNA:dGTP ternary complex
Deposited 2017-05-17
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Homooligomer;Protein × 2
PDB declaration: trimeric
|
Chain A
100–654(555 aa)
Fragment:UNP RESIDUES 100-654
Chain B
100–527(428 aa)
Fragment:UNP RESIDUES 100-527
|
Mutation:Q151M, C162S, C280S
Mutation:C162S, C280S
|
MG MAGNESIUM ION × 1
DGT 2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;20 mM bis-Tris-HCl pH 6.0, 60 mM di-ammonium hydrogen citrate, 20 mM MgCl2, 1.5-3% PEG 6000, 2-4% sucrose, 4-8% glycerol
|
Resolution 2.38 Å
R-free 0.223
|
|
5XN2
HIV-1 reverse transcriptase Q151M:DNA:dGTP ternary complex
Deposited 2017-05-17
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein–DNA
Homooligomer;Protein × 2
PDB declaration: trimeric
|
Chain C
100–654(555 aa)
Fragment:UNP RESIDUES 100-654
Chain D
100–527(428 aa)
Fragment:UNP RESIDUES 100-527
|
Mutation:Q151M, C162S, C280S
Mutation:C162S, C280S
|
MG MAGNESIUM ION × 1
DGT 2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;20 mM bis-Tris-HCl pH 6.0, 60 mM di-ammonium hydrogen citrate, 20 mM MgCl2, 1.5-3% PEG 6000, 2-4% sucrose, 4-8% glycerol
|
Resolution 2.38 Å
R-free 0.223
|
|
6IK9
HIV-1 reverse transcriptase with Q151M/G112S/D113A/Y115F/F116Y/F160L/I159L:DNA:dGTP ternary complex
Deposited 2018-10-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 2
PDB declaration: trimeric
|
Chain A
100–654(555 aa)
|
Mutation:G211S, D212A, Y214F, F215Y, Q250M, I258L, F259L, C261S, C379S
|
DGT 2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;20 mM Bis-Tris-HCl PH 6.0, 30-40 mM di-ammonium hydrogen citrate, 20 mM MgCl2, 3.5-4% PEG 6000, 2.4% sucrose, 4.8% glycerol
|
Resolution 2.44 Å
R-free 0.225
|
|
6IK9
HIV-1 reverse transcriptase with Q151M/G112S/D113A/Y115F/F116Y/F160L/I159L:DNA:dGTP ternary complex
Deposited 2018-10-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–DNA
Heteromer;Protein × 2
PDB declaration: trimeric
|
Chain C
100–654(555 aa)
|
Mutation:G211S, D212A, Y214F, F215Y, Q250M, I258L, F259L, C261S, C379S
|
DGT 2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE × 1
MG MAGNESIUM ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;20 mM Bis-Tris-HCl PH 6.0, 30-40 mM di-ammonium hydrogen citrate, 20 mM MgCl2, 3.5-4% PEG 6000, 2.4% sucrose, 4.8% glycerol
|
Resolution 2.44 Å
R-free 0.225
|
|
6IKA
HIV-1 reverse transcriptase with Q151M/G112S/D113A/Y115F/F116Y/F160L/I159L:DNA:entecavir-triphosphate ternary complex
Deposited 2018-10-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein–DNA
Heteromer;Protein × 2
PDB declaration: trimeric
|
Chain A
100–654(555 aa)
|
Mutation:G211S, D212A, Y214F, F215Y, Q250M, I258L, F259L, C261S, C379S
|
ET9 [[(1R,3S,5S)-3-(2-azanyl-6-oxidanylidene-3H-purin-9-yl)-2-methylidene-5-oxidanyl-cyclopentyl]methoxy-oxidanyl-phosphory l] phosphono hydrogen phosphate × 1
GOL GLYCEROL × 2
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;20 mM Bis-Tris-HCl PH 6.0, 30-40 mM di-ammonium hydrogen citrate, 20 mM MgCl2, 3.5-4% PEG 6000, 2.4% sucrose, 4.8% glycerol
|
Resolution 2.60 Å
R-free 0.232
|
|
6IKA
HIV-1 reverse transcriptase with Q151M/G112S/D113A/Y115F/F116Y/F160L/I159L:DNA:entecavir-triphosphate ternary complex
Deposited 2018-10-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein–DNA
Heteromer;Protein × 2
PDB declaration: trimeric
|
Chain C
100–654(555 aa)
|
Mutation:G211S, D212A, Y214F, F215Y, Q250M, I258L, F259L, C261S, C379S
|
ET9 [[(1R,3S,5S)-3-(2-azanyl-6-oxidanylidene-3H-purin-9-yl)-2-methylidene-5-oxidanyl-cyclopentyl]methoxy-oxidanyl-phosphory l] phosphono hydrogen phosphate × 1
GOL GLYCEROL × 2
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;20 mM Bis-Tris-HCl PH 6.0, 30-40 mM di-ammonium hydrogen citrate, 20 mM MgCl2, 3.5-4% PEG 6000, 2.4% sucrose, 4.8% glycerol
|
Resolution 2.60 Å
R-free 0.232
|